Boston Scientific risk/reward favorable, says RBC Capital
Time to go long....
"After meeting with Boston Scientific's management, RBC Capital believes that the company's cardiac rhythm management share remains stable, while the company is poised to beat EPS expectations in 2012. The firm maintains a $6 target and Outperform rating on the stock".
Longsrboss, thank you as I had not notice this up grade.
Also, yesterday BSX hit 5.79 and was green for a short time. More importantly it recaptured its 200sma at 5.72 and closed in the upper 1/3 ot its daily bar which is bullish.
Also, "Boston Scientific to Acquire BridgePoint Medical, Inc.
Company to acquire innovative, minimally invasive technologies for the treatment of coronary chronic total occlusions"